Jardiance and Farxiga are both SGLT2 inhibitors, but the cost comparison needs each product’s indication, strength and claim result. Their assistance routes also differ, including a dated change to new Farxiga enrollment in AZ&Me.
MEDICATION COMPARATOR
Compare Jardiance and Farxiga
A quick look at some of the medication differences. Open the full Comparator for more detail and reviewed sources.
Jardiance
- Active ingredient
- Empagliflozin
- Drug class
- SGLT2 inhibitor
- Approved uses
- Type 2 diabetes from age 10; heart-failure outcomes in adults with heart failure; kidney outcomes in adults with chronic kidney disease at risk of progression. Also: cardiovascular death risk reduction in adults with type 2 diabetes and established cardiovascular disease.
- Available forms
- Film-coated tablets.
- How taken
- Film-coated tablets: by mouth, once daily.
Farxiga
- Active ingredient
- Dapagliflozin
- Drug class
- SGLT2 inhibitor
- Approved uses
- Type 2 diabetes from age 10; heart-failure outcomes in adults with heart failure; kidney outcomes in adults with chronic kidney disease at risk of progression. Also: heart-failure hospitalization risk reduction in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors.
- Available forms
- Film-coated tablets.
- How taken
- Film-coated tablets: by mouth, once daily.
US label overview. Approved uses and eligibility vary by formulation and population; see the full comparison.
Start with the reason for treatment
Both medicines have several approved uses, but the exact populations and label wording differ. Ask the clinician whether both are appropriate for the intended glucose, heart or kidney goal. A shared SGLT2 mechanism does not establish identical indications, individual outcomes or kidney-function instructions.
Compare the prescribed tablets over the same period
Use the clinician-selected strength for each medicine and request a 30- or 90-day quote on a consistent basis. A 25 mg Jardiance tablet is not numerically equivalent to a 10 mg Farxiga tablet. Do not use price per milligram as an efficacy or value measure, and do not infer that the highest strength is appropriate for every indication.
Get the personal formulary result
Ask the plan about each exact product and prescribed indication, including authorization, deductible effects and quantity limits. If one is preferred, ask what the nonpreferred product would require rather than assuming it is entirely excluded. Clinical suitability and the actual member payment should both be resolved before the comparison is actionable.
Compare US support and whole-regimen costs
Keep commercial savings, patient assistance and the cost of a complete regimen separate.
| Cost/access check | Jardiance | Farxiga |
|---|---|---|
| Commercial support | Use Jardiance’s current official eligibility pathway | Use Farxiga’s current official savings terms |
| Patient assistance | Eligibility and approval must be confirmed for the individual applicant | AZ&Me stopped accepting new Farxiga patients on May 1, 2026 |
| Whole-regimen quote | For Synjardy (adds metformin) or Glyxambi (adds linagliptin), compare the whole regimen and all claims over the same period. | For Xigduo XR (adds metformin), compare the whole regimen and all claims over the same period. |
Different savings and assistance rules
Jardiance and Farxiga have separate commercial savings terms and eligibility requirements. AZ&Me patient assistance is a different program; it stopped accepting new Farxiga patients on May 1, 2026. Existing participants should ask about their own enrollment and renewal status. An offer or application form does not by itself confirm approval.
Keep combination tablets out of a partial comparison
Synjardy and Xigduo XR include metformin, while Glyxambi includes linagliptin. Their prices describe different prescriptions. If a combination or separate-ingredient regimen is clinically considered, compare the whole regimen and all claims over the same period, with release type and duplicate ingredients reconciled.
Understanding the quotes
The Jardiance-versus-other-SGLT2 guide explains the wider medicine class, while the Farxiga insurance-and-discounts guide has more product-specific information. For a personal comparison, use dated pharmacy quotes and current official program terms. Include the prescribed supply, your eligible payment and any separate care costs for each option.
Source: [3]
Questions and answers
Can I compare Jardiance and Farxiga by cost per milligram?
No. Their milligram strengths are not an equivalence scale; compare clinically appropriate prescribed supplies.
Are their assistance routes identical?
No. Product-specific eligibility differs, and AZ&Me has stopped new Farxiga enrollment under its current notice.
Does the same SGLT2 class guarantee the same coverage?
No. The plan can process each product and indication differently.
Does a Xigduo XR price compare directly with Jardiance alone?
No. Xigduo XR adds metformin, so the full regimen must be accounted for.
Related reading
Sources
- Jardiance: official US prescribing information
- Jardiance: official manufacturer support and current terms
- HealthCare.gov: prescription coverage, formularies and exceptions
- FDA: generic drug facts
- Farxiga: official US prescribing information
- Farxiga: official manufacturer support and current terms
- AZ&Me: current program and enrollment notices
Sources checked 1 October 2026. This information does not replace advice from your healthcare professional. For complete warnings and instructions, read the product information and consult the prescribing team.
Reviewed by: Mattias Hagman, PhD
About the reviewer:
Dr Mattias Hagman (PhD, University of Sydney) has an academic background and experience working with healthcare-related content and regulated industries. He has lecturing experience at international universities, including Stockholm University and the University of Malta.
Last reviewed: October 2026